Boston News & Analysis

Evaluate the expected performance of Boston Scientific (BSX) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Boston Scientific (BSX) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BXP’s Q4 FFO per share matches estimates. Results reflect higher revenues amid healthy leasing activity. However, high interest expenses hurt.

While the top- and bottom-line numbers for Boston Properties (BXP) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Boston Properties (BXP) delivered FFO and revenue surprises of 0% and 0.37%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

In the closing of the recent trading day, Boston Scientific (BSX) stood at $102.27, denoting a +0.32% change from the preceding trading day.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Boston Scientific (BSX) closed the most recent trading day at $101.64, moving +1.33% from the previous trading session.

Looking beyond Wall Street’s top -and-bottom-line estimate forecasts for Boston Properties (BXP), delve into some of its key metrics to gain a deeper insight into the company’s potential performance for the quarter ended December 2024.

Boston Scientific announces favorable study data for its FARAPULSE PFA system and WATCHMAN FLX device at the AF Symposium 2025.

When Ministry of Supply launched the first iteration of its Mercury Intelligent Heated Jacket in 2018, voice-controlled AI was in its early heyday. The idea of a heated jacket wasn’t novel, but the ability to ask Siri or Alexa to turn it on, or to adj…

Boston Scientific (BSX) closed the most recent trading day at $98.66, moving +0.5% from the previous trading session.

The angular, divisive electric pickup truck didn’t sell as well as some Wall Street analysts expected in 2024.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The heavy selling pressure might have exhausted for Boston Beer (SAM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PBH vs. BSX: Which Stock Is the Better Value Option?

BXP secures a lease renewal and expansion with Knitwell Group at 7 Times Square in New York, highlighting the strong demand for quality office spaces.

On a recent winter day in Boston, the temperature outside was in the 20s. But inside a recently built house, it stayed around 72 degrees even though the heat wasn’t running.

“I hadn’t heard of a ‘passive house’ before I was looking for a house,” sa…

The latest trading day saw Boston Scientific (BSX) settling at $94.61, representing a -0.28% change from its previous close.

SAM benefits from strong price realization, innovation and procurement savings.

Wayfair is exiting the German market and plans to cut as many as 730 jobs, or about 3% of its global workforce, as it looks to focus on new growth drivers such as physical retail, the company said Friday. About half of the affected employees will have …

The U.S. labor market remains healthy and the Federal Reserve can take a gradual and patient approach to future rate cuts, Boston Fed President Susan Collins said Thursday.

Federal Reserve Bank of Boston President Susan Collins said on Thursday that the current outlook calls for a gradual and a patient approach to rate cuts, as reported by Reuters.

Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.

Find out which top-rated stocks like Boston Scientific have just earned a spot on IBD’s lists of the best growth stocks.
The post Boston Scientific Tops All-Time High: See New Names On IBD 50, IPO Leaders, More appeared first on Investor's Busines…

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.
The post J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product appeared first on Inv…

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.
The post Boston Scientific Surges On $900 Million Takeover Of Bolt Medical appeared first on Investor's Business Daily.

Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company’s fundamentals for clues.

Boston Scientific (BSX) reachead $91.99 at the closing of the latest trading day, reflecting a +0.77% change compared to its last close.

Boston Scientific successfully continues its expansion of operations across different geographies outside the United States.

In the most recent trading session, Boston Scientific (BSX) closed at $91.29, indicating a +0.66% shift from the previous trading day.

Here is how Boston Scientific (BSX) and Aclarion, Inc. (ACON) have performed compared to their sector so far this year.

Mutual Fund Report for FSDAX

Invest in Eaton Vance mutual funds like EVIFX, EAPCX and EAERX for sustainable returns.

Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN’s performance.